70 related articles for article (PubMed ID: 33766752)
1. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
You H; Wei L; Kaminska B
Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
[TBL] [Abstract][Full Text] [Related]
2. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis.
Shi H; Sun X; Wu Y; Cui Q; Sun S; Ji N; Liu Y
J Clin Neurosci; 2024 Jun; 124():36-46. PubMed ID: 38642434
[TBL] [Abstract][Full Text] [Related]
3. Understanding the molecular pathogenesis of primary central nervous system lymphoma by experimental animal models.
Wu D; Liu D; Tateishi K; Qi F; Yang F; Ke C; You H
J Cell Physiol; 2023 Oct; 238(10):2191-2205. PubMed ID: 37642377
[TBL] [Abstract][Full Text] [Related]
4. Development of a contacting transwell co-culture system for the
Nishi M; Tateishi K; Sundararaj JS; Ino Y; Nakai Y; Hatayama Y; Yamaoka Y; Mihana Y; Miyakawa K; Kimura H; Kimura Y; Yamamoto T; Ryo A
Front Cell Dev Biol; 2023; 11():1275519. PubMed ID: 38089883
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?
Grommes C
J Clin Oncol; 2023 Mar; 41(9):1649-1651. PubMed ID: 36669147
[No Abstract] [Full Text] [Related]
6. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging therapies for primary central nervous system lymphoma.
Yuan Y; Ding T; Wang S; Chen H; Mao Y; Chen T
Biomark Res; 2021 May; 9(1):32. PubMed ID: 33957995
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies.
Schaff LR; Ambady P; Doolittle ND; Grommes C
Ann Lymphoma; 2021 Mar; 5():. PubMed ID: 33912868
[TBL] [Abstract][Full Text] [Related]
9. A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity.
Boulch M; Cazaux M; Loe-Mie Y; Thibaut R; Corre B; Lemaître F; Grandjean CL; Garcia Z; Bousso P
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33771887
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant.
Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS
JAMA Oncol; 2021 Jul; 7(7):993-1003. PubMed ID: 33956047
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography With or Without Computed Tomography in Patients With Primary Central Nervous System Lymphoma: Updated Systematic Review and Diagnostic Test Accuracy Meta-analyses.
Gupta T; Manjali JJ; Kannan S; Purandare N; Rangarajan V
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):497-507. PubMed ID: 33947632
[TBL] [Abstract][Full Text] [Related]
12. Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics.
Ochocka N; Kaminska B
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809675
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin and Its Binding Proteins in Parkinson's Disease.
Bohush A; Leśniak W; Weis S; Filipek A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809535
[TBL] [Abstract][Full Text] [Related]
14. Central Apparatus, the Molecular Kickstarter of Ciliary and Flagellar Nanomachines.
Samsel Z; Sekretarska J; Osinka A; Wloga D; Joachimiak E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809498
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNAs-Crucial Players Organizing the Landscape of the Neuronal Nucleus.
Sas-Nowosielska H; Magalska A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801737
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade.
Roussel M; Le KS; Granier C; Llamas Gutierrez F; Foucher E; Le Gallou S; Pangault C; Xerri L; Launay V; Lamy T; Tartour E; Olive D; Fest T
Blood Adv; 2021 Apr; 5(7):1816-1829. PubMed ID: 33787861
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma presenting with Parkinsonism as an initial manifestation: A case report and literature review.
Okano R; Suzuki K; Nakano Y; Yamamoto J
Mol Clin Oncol; 2021 May; 14(5):95. PubMed ID: 33767864
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development.
Tateishi K; Miyake Y; Nakamura T; Yamamoto T
Brain Tumor Pathol; 2021 Jul; 38(3):173-182. PubMed ID: 34255226
[TBL] [Abstract][Full Text] [Related]
19. Recent Progress on Primary Central Nervous System Lymphoma-From Bench to Bedside.
Shao L; Xu C; Wu H; Jamal M; Pan S; Li S; Chen F; Yu D; Liu K; Wei Y
Front Oncol; 2021; 11():689843. PubMed ID: 34485125
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
